GlobeStar Therapeutics GSTC Stock
GlobeStar Therapeutics Price Chart
GlobeStar Therapeutics GSTC Financial and Trading Overview
| GlobeStar Therapeutics stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0.0001 USD x 0 |
| Ask | 0.0002 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.0001 USD |
| Volume | 300K USD |
| Avg. Volume | 0 USD |
| Market Cap | 124.11K USD |
| Beta (5Y Monthly) | 1.081 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GSTC Valuation Measures
| Enterprise Value | 331.38K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.0004 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
GlobeStar Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.081 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
GSTC Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 1.24B |
| Float | 1.15B |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2023 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | September 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -919297 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41 USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 329.05K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.049 |
| Book Value Per Share (mrq) | -0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -148283 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of GlobeStar Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 1280 Lexington Avenue |
| ZIP | 10028 |
| Phone | 509-531-1671 |
| Website | https://www.globestartherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.
Q&A For GlobeStar Therapeutics Stock
What is a current GSTC stock price?
GlobeStar Therapeutics GSTC stock price today per share is 0.0001 USD.
How to purchase GlobeStar Therapeutics stock?
You can buy GSTC shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GlobeStar Therapeutics?
The stock symbol or ticker of GlobeStar Therapeutics is GSTC.
Which industry does the GlobeStar Therapeutics company belong to?
The GlobeStar Therapeutics industry is Biotechnology.
How many shares does GlobeStar Therapeutics have in circulation?
The max supply of GlobeStar Therapeutics shares is 1.24B.
What is GlobeStar Therapeutics Price to Earnings Ratio (PE Ratio)?
GlobeStar Therapeutics PE Ratio is now.
What was GlobeStar Therapeutics earnings per share over the trailing 12 months (TTM)?
GlobeStar Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the GlobeStar Therapeutics company belong to?
The GlobeStar Therapeutics sector is Healthcare.